Suppr超能文献

对比剂致急性肾损伤的风险预测因素。

Risk Predictors for Postcontrast Acute Kidney Injury.

机构信息

UTHealth School of Public Health, Houston, Texas.

UTHealth School of Public Health, Houston, Texas.

出版信息

J Am Coll Radiol. 2018 Nov;15(11):1547-1552. doi: 10.1016/j.jacr.2018.04.015. Epub 2018 May 22.

Abstract

OBJECTIVE

To evaluate risk predictors of acute kidney injury (AKI) after contrast-media procedures in a broader cohort of patients than previously reported.

DATA SOURCES

Comprehensive medical and pharmacy commercial claims data from 2012 to 2014.

DATA COLLECTION AND EXTRACTION METHODS

Claims associated with contrast-media procedures for 2,737,020 persons between January 1, 2012 and November 30, 2014, were reviewed.

PRINCIPAL FINDINGS

The overall incidence of AKI after a contrast-media procedure was 0.85%. AKI occurred in 26% of cases that had two or more contrast procedures within 30 days, compared with 9% of non-AKI cases. Although the incidence of postcontrast AKI was low, 10% of patients who developed AKI had a recent previous episode of AKI. In cases when AKI had occurred within 180 days of contrast administration, the odds of subsequent kidney injury was 9.39.

CONCLUSIONS

Overall, there is a low risk (0.85%) of developing an AKI after a procedure with contrast-media consistent with several recent studies. However, in adults with a recent history of AKI, physicians must consider this history as a risk factor for subsequent AKI.

摘要

目的

评估比以往报道更广泛患者人群中造影剂检查后急性肾损伤(AKI)的风险预测因素。

资料来源

2012 年至 2014 年全面的医疗和药品商业理赔数据。

资料收集和提取方法

对 2012 年 1 月 1 日至 2014 年 11 月 30 日期间进行造影剂检查的 2737020 人进行了回顾性分析。

主要发现

造影剂检查后 AKI 的总体发生率为 0.85%。在 30 天内进行两次或两次以上造影检查的病例中,AKI 发生率为 26%,而非 AKI 病例的发生率为 9%。虽然造影后 AKI 的发生率较低,但 10%发生 AKI 的患者最近曾发生 AKI。在造影后 180 天内发生 AKI 的情况下,发生后续肾脏损伤的几率为 9.39。

结论

总体而言,造影剂检查后发生 AKI 的风险较低(0.85%),与几项最近的研究一致。然而,对于有近期 AKI 病史的成年人,医生必须将其病史视为发生后续 AKI 的风险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验